Knights Of Columbus Asset Advisors LLC Amicus Therapeutics, Inc. Transaction History
Knights Of Columbus Asset Advisors LLC
- $1.47 Billion
- Q4 2024
A detailed history of Knights Of Columbus Asset Advisors LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Knights Of Columbus Asset Advisors LLC holds 5,842 shares of FOLD stock, worth $53,220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,842
Previous 6,231
6.24%
Holding current value
$53,220
Previous $66,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
311MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$267 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA28.5MShares$259 Million0.05% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$222 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$221 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$211 Million3.18% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.56B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...